Evidence map›Paper›PMID 38741192›Full record

ArticleCritical care (London, England)2024

Potential implications of long-acting GLP-1 receptor agonists for critically ill.

Luping Wang, Hao Yang, Xiaoxiao Xia, Bo Wang, Qin Wu

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luping WangDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Hao YangDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xiaoxiao XiaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Bo WangDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Qin WuDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. Qinwu0221@gmail.com.

Funding

1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University ZYJC18006Chengdu Science and Technology Bureau 2021-YF05-00071-SNChina National Key Research and Development Program No. 2020AAA0105005Key Research and Development Project of Science and Technology Department of Sichuan Province 2021YFS0003National Natural Science Foundation of China 81901998
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Critical IllnessGlucagon-Like Peptide-1 Receptor AgonistsHumansHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Identifiers

PMID38741192
PMCPMC11091986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.